Systematic review: second‐generation vs. conventional corticosteroids for induction of remission in ulcerative colitis von D'Haens, G.

Volltext

Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials von Jairath, V., Khanna, R., Zou, G. Y., Stitt, L., Mosli, M., Vandervoort, M. K., D'Haens, G., Sandborn, W. J., Feagan, B. G., Levesque, B. G.

Volltext

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity von Khanna, R., Zou, G., D'Haens, G., Feagan, B. G., Sandborn, W. J., Vandervoort, M. K., Rolleri, R. L., Bortey, E., Paterson, C., Forbes, W. P., Levesque, B. G.

Volltext

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function von De Vries, L C S, Duarte, J M, De Krijger, M, Welting, O, Van Hamersveld, P H P, Van Leeuwen-Hilbers, F W M, Moerland, P D, Jongejan, A, D'Haens, G R, De Jonge, W J, Wildenberg, M E

Volltext

Review article: defining remission in ulcerative colitis von Travis, S. P. L., Higgins, P. D. R., Orchard, T., Van Der Woude, C. J., Panaccione, R., Bitton, A., O’Morain, C., Panés, J., Sturm, A., Reinisch, W., Kamm, M. A., D’Haens, G.

Volltext

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease von Vermeire, Severine, Noman, Maja, Van Assche, Gert, Baert, Filip, D’Haens, Geert, Rutgeerts, Paul

Volltext

Prospective cohort study of appendicectomy for treatment of therapy‐refractory ulcerative colitis von Stellingwerf, M. E., Sahami, S., Winter, D. C., Martin, S. T., D'Haens, G. R., Cullen, G., Doherty, G. A., Mulcahy, H., Bemelman, W. A., Buskens, C. J.

Volltext

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials von Vuitton, L, Marteau, P, Sandborn, W J, Levesque, B G, Feagan, B, Vermeire, S, Danese, S, D'Haens, G, Lowenberg, M, Khanna, R, Fiorino, G, Travis, S, Mary, J Y, Peyrin-Biroulet, L

Volltext

Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic... von Peyrin-Biroulet, L., Bossuyt, P., Bettenworth, D., Loftus, E. V., Anjie, S. I., D’Haens, G., Saruta, M., Arkkila, P., Park, H., Choi, D., Kim, D- H., Reinisch, W.

Volltext

Adalimumab for the treatment of fistulas in patients with Crohn’s disease von Colombel, J-F, Schwartz, D A, Sandborn, W J, Kamm, M A, D’Haens, G, Rutgeerts, P, Enns, R, Panaccione, R, Schreiber, S, Li, J, Kent, J D, Lomax, K G, Pollack, P F

Volltext

Suppression of anti‐drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease von Strik, A. S., Brink, G. R., Ponsioen, C., Mathot, R., Löwenberg, M., D'Haens, G. R.

Volltext

Review article: dose optimisation of infliximab for acute severe ulcerative colitis von Hindryckx, P., Novak, G., Vande Casteele, N., Laukens, D., Parker, C., Shackelton, L. M, Narula, N., Khanna, R., Dulai, P., Levesque, B. G, Sandborn, W. J, D'Haens, G., Feagan, B. G., Jairath, V.

Volltext

Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation: Short-Term Results of the PASSION Study von Sahami, S, Wildenberg, M E, Koens, L, Doherty, G, Martin, S, D’Haens, G R A M, Cullen, G, Bemelman, W A, Winter, D, Buskens, C J

Volltext

Clinical Decision Support Tools: The Evolution of a Revolution von Mould, DR, D'Haens, G, Upton, RN

Volltext

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Volltext

Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres von de Buck van Overstraeten, A., Eshuis, E. J., Vermeire, S., Van Assche, G., Ferrante, M., D'Haens, G. R., Ponsioen, C. Y., Belmans, A., Buskens, C. J., Wolthuis, A. M., Bemelman, W. A., D'Hoore, A.

Volltext

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease von PANACCIONE, R., COLOMBEL, J.‐F., SANDBORN, W. J., RUTGEERTS, P., D’HAENS, G. R., ROBINSON, A. M., CHAO, J., MULANI, P. M., POLLACK, P. F.

Volltext

Reliability of histologic assessment in patients with eosinophilic oesophagitis von Warners, M. J., Ambarus, C. A., Bredenoord, A. J., Verheij, J., Lauwers, G. Y., Walsh, J. C., Katzka, D. A., Nelson, S., Viegen, T., Furuta, G. T., Gupta, S. K., Stitt, L., Zou, G., Parker, C. E., Shackelton, L. M., D`Haens, G. R., Sandborn, W. J., Dellon, E. S., Feagan, B. G., Collins, M. H., Jairath, V., Pai, R. K.

Volltext

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease von De Vries, L C S, Wildenberg, M E, De Jonge, W J, D'Haens, G R

Volltext

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum von D'Haens, Geert R., Geboes ‡, Karel, Peeters, Mark, Baert, Filip, Penninckx §, Freddy, Rutgeerts, Paul

Volltext